nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—SLCO1A2—Rosuvastatin—atherosclerosis	0.0827	0.112	CbGbCtD
Spironolactone—SLCO1A2—Simvastatin—atherosclerosis	0.0769	0.104	CbGbCtD
Spironolactone—SLCO1A2—Lovastatin—atherosclerosis	0.0753	0.101	CbGbCtD
Spironolactone—SLCO1A2—Pravastatin—atherosclerosis	0.0753	0.101	CbGbCtD
Spironolactone—ABCC2—Ezetimibe—atherosclerosis	0.0686	0.0925	CbGbCtD
Spironolactone—ABCC2—Simvastatin—atherosclerosis	0.0638	0.086	CbGbCtD
Spironolactone—ABCC2—Lovastatin—atherosclerosis	0.0624	0.0841	CbGbCtD
Spironolactone—ABCC2—Pravastatin—atherosclerosis	0.0624	0.0841	CbGbCtD
Spironolactone—CYP2C8—Simvastatin—atherosclerosis	0.0307	0.0414	CbGbCtD
Spironolactone—CYP2C8—Pravastatin—atherosclerosis	0.0301	0.0405	CbGbCtD
Spironolactone—CYP2C8—Lovastatin—atherosclerosis	0.0301	0.0405	CbGbCtD
Spironolactone—ABCB1—Ezetimibe—atherosclerosis	0.0224	0.0301	CbGbCtD
Spironolactone—ABCB1—Simvastatin—atherosclerosis	0.0208	0.028	CbGbCtD
Spironolactone—ABCB1—Pravastatin—atherosclerosis	0.0203	0.0274	CbGbCtD
Spironolactone—ABCB1—Lovastatin—atherosclerosis	0.0203	0.0274	CbGbCtD
Spironolactone—SHBG—hindlimb—atherosclerosis	0.00401	0.142	CbGeAlD
Spironolactone—AR—penis—atherosclerosis	0.00381	0.135	CbGeAlD
Spironolactone—Gastrointestinal symptom NOS—Niacin—atherosclerosis	0.00284	0.025	CcSEcCtD
Spironolactone—PGR—artery—atherosclerosis	0.00222	0.0784	CbGeAlD
Spironolactone—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00205	0.018	CcSEcCtD
Spironolactone—Vasculitis—Lovastatin—atherosclerosis	0.00199	0.0175	CcSEcCtD
Spironolactone—Vasculitis—Ezetimibe—atherosclerosis	0.00195	0.0172	CcSEcCtD
Spironolactone—Breast pain—Niacin—atherosclerosis	0.00191	0.0168	CcSEcCtD
Spironolactone—CYP11B2—cardiovascular system—atherosclerosis	0.00188	0.0664	CbGeAlD
Spironolactone—Vasculitis—Simvastatin—atherosclerosis	0.00186	0.0164	CcSEcCtD
Spironolactone—Renal failure acute—Rosuvastatin—atherosclerosis	0.0018	0.0159	CcSEcCtD
Spironolactone—Gynaecomastia—Lovastatin—atherosclerosis	0.00174	0.0153	CcSEcCtD
Spironolactone—PGR—blood vessel—atherosclerosis	0.00173	0.0611	CbGeAlD
Spironolactone—Vasculitis—Pravastatin—atherosclerosis	0.00168	0.0148	CcSEcCtD
Spironolactone—Gynaecomastia—Simvastatin—atherosclerosis	0.00163	0.0143	CcSEcCtD
Spironolactone—Cramps of lower extremities—Niacin—atherosclerosis	0.00153	0.0135	CcSEcCtD
Spironolactone—Gynaecomastia—Pravastatin—atherosclerosis	0.00147	0.0129	CcSEcCtD
Spironolactone—Renal failure acute—Pravastatin—atherosclerosis	0.00129	0.0114	CcSEcCtD
Spironolactone—Cramp muscle—Lovastatin—atherosclerosis	0.00127	0.0112	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00127	0.0112	CcSEcCtD
Spironolactone—Cramp muscle—Ezetimibe—atherosclerosis	0.00125	0.011	CcSEcCtD
Spironolactone—Gastritis—Ezetimibe—atherosclerosis	0.00123	0.0108	CcSEcCtD
Spironolactone—Eosinophilia—Lovastatin—atherosclerosis	0.00121	0.0106	CcSEcCtD
Spironolactone—Cramp muscle—Simvastatin—atherosclerosis	0.00119	0.0105	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00119	0.0105	CcSEcCtD
Spironolactone—Eosinophilia—Ezetimibe—atherosclerosis	0.00118	0.0104	CcSEcCtD
Spironolactone—Gastritis—Simvastatin—atherosclerosis	0.00117	0.0103	CcSEcCtD
Spironolactone—Eosinophilia—Simvastatin—atherosclerosis	0.00113	0.00993	CcSEcCtD
Spironolactone—Erectile dysfunction—Lovastatin—atherosclerosis	0.00112	0.00988	CcSEcCtD
Spironolactone—Erectile dysfunction—Ezetimibe—atherosclerosis	0.0011	0.00969	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00108	0.00948	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00107	0.00945	CcSEcCtD
Spironolactone—Cramp muscle—Pravastatin—atherosclerosis	0.00107	0.00945	CcSEcCtD
Spironolactone—Erectile dysfunction—Simvastatin—atherosclerosis	0.00105	0.00924	CcSEcCtD
Spironolactone—Eosinophilia—Pravastatin—atherosclerosis	0.00102	0.00898	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00101	0.00887	CcSEcCtD
Spironolactone—SHBG—connective tissue—atherosclerosis	0.000982	0.0348	CbGeAlD
Spironolactone—Erectile dysfunction—Niacin—atherosclerosis	0.000965	0.00848	CcSEcCtD
Spironolactone—NR3C2—connective tissue—atherosclerosis	0.000952	0.0337	CbGeAlD
Spironolactone—Erectile dysfunction—Pravastatin—atherosclerosis	0.00095	0.00835	CcSEcCtD
Spironolactone—Erythema multiforme—Lovastatin—atherosclerosis	0.000923	0.00812	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000912	0.00802	CcSEcCtD
Spironolactone—Erythema multiforme—Ezetimibe—atherosclerosis	0.000906	0.00796	CcSEcCtD
Spironolactone—PGR—connective tissue—atherosclerosis	0.000885	0.0313	CbGeAlD
Spironolactone—Erythema multiforme—Simvastatin—atherosclerosis	0.000864	0.00759	CcSEcCtD
Spironolactone—Alopecia—Lovastatin—atherosclerosis	0.000863	0.00759	CcSEcCtD
Spironolactone—SHBG—cardiovascular system—atherosclerosis	0.000855	0.0302	CbGeAlD
Spironolactone—Alopecia—Ezetimibe—atherosclerosis	0.000846	0.00744	CcSEcCtD
Spironolactone—NR3C2—cardiovascular system—atherosclerosis	0.000828	0.0293	CbGeAlD
Spironolactone—Confusional state—Rosuvastatin—atherosclerosis	0.000826	0.00726	CcSEcCtD
Spironolactone—Muscle spasms—Lovastatin—atherosclerosis	0.000817	0.00718	CcSEcCtD
Spironolactone—Alopecia—Simvastatin—atherosclerosis	0.000807	0.0071	CcSEcCtD
Spironolactone—Muscle spasms—Ezetimibe—atherosclerosis	0.000802	0.00705	CcSEcCtD
Spironolactone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000802	0.00705	CcSEcCtD
Spironolactone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000789	0.00693	CcSEcCtD
Spironolactone—Erythema multiforme—Pravastatin—atherosclerosis	0.000781	0.00686	CcSEcCtD
Spironolactone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000774	0.0068	CcSEcCtD
Spironolactone—PGR—cardiovascular system—atherosclerosis	0.00077	0.0272	CbGeAlD
Spironolactone—Malaise—Lovastatin—atherosclerosis	0.000767	0.00674	CcSEcCtD
Spironolactone—Muscle spasms—Simvastatin—atherosclerosis	0.000765	0.00672	CcSEcCtD
Spironolactone—Leukopenia—Lovastatin—atherosclerosis	0.000761	0.00669	CcSEcCtD
Spironolactone—SHBG—adipose tissue—atherosclerosis	0.000754	0.0267	CbGeAlD
Spironolactone—Malaise—Ezetimibe—atherosclerosis	0.000752	0.00661	CcSEcCtD
Spironolactone—Alopecia—Niacin—atherosclerosis	0.000741	0.00651	CcSEcCtD
Spironolactone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000738	0.00649	CcSEcCtD
Spironolactone—NR3C2—adipose tissue—atherosclerosis	0.00073	0.0258	CbGeAlD
Spironolactone—Alopecia—Pravastatin—atherosclerosis	0.00073	0.00641	CcSEcCtD
Spironolactone—Malaise—Simvastatin—atherosclerosis	0.000717	0.0063	CcSEcCtD
Spironolactone—Discomfort—Lovastatin—atherosclerosis	0.000715	0.00629	CcSEcCtD
Spironolactone—Leukopenia—Simvastatin—atherosclerosis	0.000712	0.00626	CcSEcCtD
Spironolactone—AR—connective tissue—atherosclerosis	0.000705	0.0249	CbGeAlD
Spironolactone—Muscle spasms—Niacin—atherosclerosis	0.000702	0.00617	CcSEcCtD
Spironolactone—Discomfort—Ezetimibe—atherosclerosis	0.000701	0.00616	CcSEcCtD
Spironolactone—Confusional state—Lovastatin—atherosclerosis	0.0007	0.00615	CcSEcCtD
Spironolactone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000694	0.0061	CcSEcCtD
Spironolactone—Muscle spasms—Pravastatin—atherosclerosis	0.000691	0.00608	CcSEcCtD
Spironolactone—Confusional state—Ezetimibe—atherosclerosis	0.000686	0.00603	CcSEcCtD
Spironolactone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000681	0.00598	CcSEcCtD
Spironolactone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000679	0.00597	CcSEcCtD
Spironolactone—PGR—adipose tissue—atherosclerosis	0.000679	0.024	CbGeAlD
Spironolactone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000675	0.00593	CcSEcCtD
Spironolactone—Discomfort—Simvastatin—atherosclerosis	0.000669	0.00588	CcSEcCtD
Spironolactone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000667	0.00586	CcSEcCtD
Spironolactone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000666	0.00586	CcSEcCtD
Spironolactone—Confusional state—Simvastatin—atherosclerosis	0.000654	0.00575	CcSEcCtD
Spironolactone—Leukopenia—Niacin—atherosclerosis	0.000654	0.00574	CcSEcCtD
Spironolactone—Urticaria—Rosuvastatin—atherosclerosis	0.00065	0.00572	CcSEcCtD
Spironolactone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000649	0.0057	CcSEcCtD
Spironolactone—Malaise—Pravastatin—atherosclerosis	0.000648	0.0057	CcSEcCtD
Spironolactone—Leukopenia—Pravastatin—atherosclerosis	0.000644	0.00566	CcSEcCtD
Spironolactone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000635	0.00559	CcSEcCtD
Spironolactone—AR—cardiovascular system—atherosclerosis	0.000613	0.0217	CbGeAlD
Spironolactone—Discomfort—Pravastatin—atherosclerosis	0.000605	0.00532	CcSEcCtD
Spironolactone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000603	0.0053	CcSEcCtD
Spironolactone—Anaphylactic shock—Niacin—atherosclerosis	0.000596	0.00524	CcSEcCtD
Spironolactone—Confusional state—Pravastatin—atherosclerosis	0.000592	0.0052	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000588	0.00516	CcSEcCtD
Spironolactone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000587	0.00516	CcSEcCtD
Spironolactone—Pruritus—Rosuvastatin—atherosclerosis	0.000579	0.00509	CcSEcCtD
Spironolactone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000574	0.00505	CcSEcCtD
Spironolactone—Feeling abnormal—Lovastatin—atherosclerosis	0.000572	0.00503	CcSEcCtD
Spironolactone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000561	0.00493	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00056	0.00492	CcSEcCtD
Spironolactone—Diarrhoea—Rosuvastatin—atherosclerosis	0.00056	0.00492	CcSEcCtD
Spironolactone—Urticaria—Lovastatin—atherosclerosis	0.000551	0.00484	CcSEcCtD
Spironolactone—Body temperature increased—Lovastatin—atherosclerosis	0.000548	0.00482	CcSEcCtD
Spironolactone—Dizziness—Rosuvastatin—atherosclerosis	0.000541	0.00476	CcSEcCtD
Spironolactone—AR—adipose tissue—atherosclerosis	0.000541	0.0191	CbGeAlD
Spironolactone—Urticaria—Ezetimibe—atherosclerosis	0.000541	0.00475	CcSEcCtD
Spironolactone—Body temperature increased—Ezetimibe—atherosclerosis	0.000538	0.00473	CcSEcCtD
Spironolactone—Feeling abnormal—Simvastatin—atherosclerosis	0.000535	0.0047	CcSEcCtD
Spironolactone—ABCB1—blood vessel—atherosclerosis	0.000533	0.0189	CbGeAlD
Spironolactone—Somnolence—Niacin—atherosclerosis	0.00053	0.00466	CcSEcCtD
Spironolactone—SHBG—liver—atherosclerosis	0.000528	0.0187	CbGeAlD
Spironolactone—Rash—Rosuvastatin—atherosclerosis	0.000516	0.00454	CcSEcCtD
Spironolactone—Dermatitis—Rosuvastatin—atherosclerosis	0.000516	0.00453	CcSEcCtD
Spironolactone—Urticaria—Simvastatin—atherosclerosis	0.000516	0.00453	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000514	0.00452	CcSEcCtD
Spironolactone—Body temperature increased—Simvastatin—atherosclerosis	0.000513	0.00451	CcSEcCtD
Spironolactone—Headache—Rosuvastatin—atherosclerosis	0.000513	0.00451	CcSEcCtD
Spironolactone—NR3C2—liver—atherosclerosis	0.000512	0.0181	CbGeAlD
Spironolactone—Hypersensitivity—Lovastatin—atherosclerosis	0.000511	0.00449	CcSEcCtD
Spironolactone—NR3C1—connective tissue—atherosclerosis	0.000511	0.0181	CbGeAlD
Spironolactone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000501	0.00441	CcSEcCtD
Spironolactone—Pruritus—Lovastatin—atherosclerosis	0.000491	0.00431	CcSEcCtD
Spironolactone—Nausea—Rosuvastatin—atherosclerosis	0.000486	0.00427	CcSEcCtD
Spironolactone—Feeling abnormal—Pravastatin—atherosclerosis	0.000484	0.00425	CcSEcCtD
Spironolactone—Pruritus—Ezetimibe—atherosclerosis	0.000481	0.00423	CcSEcCtD
Spironolactone—Hypersensitivity—Simvastatin—atherosclerosis	0.000478	0.0042	CcSEcCtD
Spironolactone—Diarrhoea—Lovastatin—atherosclerosis	0.000475	0.00417	CcSEcCtD
Spironolactone—Urticaria—Niacin—atherosclerosis	0.000473	0.00416	CcSEcCtD
Spironolactone—Body temperature increased—Niacin—atherosclerosis	0.000471	0.00414	CcSEcCtD
Spironolactone—Urticaria—Pravastatin—atherosclerosis	0.000466	0.0041	CcSEcCtD
Spironolactone—Diarrhoea—Ezetimibe—atherosclerosis	0.000466	0.00409	CcSEcCtD
Spironolactone—Body temperature increased—Pravastatin—atherosclerosis	0.000464	0.00408	CcSEcCtD
Spironolactone—Pruritus—Simvastatin—atherosclerosis	0.000459	0.00404	CcSEcCtD
Spironolactone—Dizziness—Lovastatin—atherosclerosis	0.000459	0.00403	CcSEcCtD
Spironolactone—Dizziness—Ezetimibe—atherosclerosis	0.00045	0.00396	CcSEcCtD
Spironolactone—NR3C1—cardiovascular system—atherosclerosis	0.000444	0.0157	CbGeAlD
Spironolactone—Diarrhoea—Simvastatin—atherosclerosis	0.000444	0.0039	CcSEcCtD
Spironolactone—Vomiting—Lovastatin—atherosclerosis	0.000441	0.00388	CcSEcCtD
Spironolactone—Hypersensitivity—Niacin—atherosclerosis	0.000439	0.00386	CcSEcCtD
Spironolactone—SLCO1A2—liver—atherosclerosis	0.000439	0.0155	CbGeAlD
Spironolactone—Rash—Lovastatin—atherosclerosis	0.000437	0.00385	CcSEcCtD
Spironolactone—Dermatitis—Lovastatin—atherosclerosis	0.000437	0.00384	CcSEcCtD
Spironolactone—Headache—Lovastatin—atherosclerosis	0.000435	0.00382	CcSEcCtD
Spironolactone—Vomiting—Ezetimibe—atherosclerosis	0.000433	0.0038	CcSEcCtD
Spironolactone—Hypersensitivity—Pravastatin—atherosclerosis	0.000432	0.0038	CcSEcCtD
Spironolactone—Dizziness—Simvastatin—atherosclerosis	0.000429	0.00377	CcSEcCtD
Spironolactone—Rash—Ezetimibe—atherosclerosis	0.000429	0.00377	CcSEcCtD
Spironolactone—Dermatitis—Ezetimibe—atherosclerosis	0.000429	0.00377	CcSEcCtD
Spironolactone—Headache—Ezetimibe—atherosclerosis	0.000426	0.00375	CcSEcCtD
Spironolactone—Pruritus—Niacin—atherosclerosis	0.000422	0.00371	CcSEcCtD
Spironolactone—Pruritus—Pravastatin—atherosclerosis	0.000415	0.00365	CcSEcCtD
Spironolactone—Vomiting—Simvastatin—atherosclerosis	0.000413	0.00363	CcSEcCtD
Spironolactone—Nausea—Lovastatin—atherosclerosis	0.000412	0.00362	CcSEcCtD
Spironolactone—Rash—Simvastatin—atherosclerosis	0.000409	0.0036	CcSEcCtD
Spironolactone—ABCC2—liver—atherosclerosis	0.000409	0.0145	CbGeAlD
Spironolactone—Dermatitis—Simvastatin—atherosclerosis	0.000409	0.00359	CcSEcCtD
Spironolactone—Diarrhoea—Niacin—atherosclerosis	0.000408	0.00358	CcSEcCtD
Spironolactone—Headache—Simvastatin—atherosclerosis	0.000407	0.00357	CcSEcCtD
Spironolactone—Nausea—Ezetimibe—atherosclerosis	0.000404	0.00355	CcSEcCtD
Spironolactone—Diarrhoea—Pravastatin—atherosclerosis	0.000401	0.00353	CcSEcCtD
Spironolactone—Dizziness—Niacin—atherosclerosis	0.000394	0.00346	CcSEcCtD
Spironolactone—NR3C1—adipose tissue—atherosclerosis	0.000392	0.0139	CbGeAlD
Spironolactone—Dizziness—Pravastatin—atherosclerosis	0.000388	0.00341	CcSEcCtD
Spironolactone—Nausea—Simvastatin—atherosclerosis	0.000385	0.00339	CcSEcCtD
Spironolactone—AR—liver—atherosclerosis	0.000379	0.0134	CbGeAlD
Spironolactone—Vomiting—Niacin—atherosclerosis	0.000379	0.00333	CcSEcCtD
Spironolactone—Rash—Niacin—atherosclerosis	0.000376	0.0033	CcSEcCtD
Spironolactone—Dermatitis—Niacin—atherosclerosis	0.000375	0.0033	CcSEcCtD
Spironolactone—Headache—Niacin—atherosclerosis	0.000373	0.00328	CcSEcCtD
Spironolactone—Vomiting—Pravastatin—atherosclerosis	0.000373	0.00328	CcSEcCtD
Spironolactone—Rash—Pravastatin—atherosclerosis	0.00037	0.00325	CcSEcCtD
Spironolactone—Dermatitis—Pravastatin—atherosclerosis	0.00037	0.00325	CcSEcCtD
Spironolactone—Headache—Pravastatin—atherosclerosis	0.000368	0.00323	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—atherosclerosis	0.00036	0.281	CrCbGaD
Spironolactone—Nausea—Niacin—atherosclerosis	0.000354	0.00311	CcSEcCtD
Spironolactone—Nausea—Pravastatin—atherosclerosis	0.000349	0.00306	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.000309	0.241	CrCbGaD
Spironolactone—CYP2C8—liver—atherosclerosis	0.000307	0.0109	CbGeAlD
Spironolactone—NR3C1—liver—atherosclerosis	0.000275	0.00972	CbGeAlD
Spironolactone—ABCB1—cardiovascular system—atherosclerosis	0.000238	0.00842	CbGeAlD
Spironolactone—Drospirenone—PTGS2—atherosclerosis	0.000231	0.18	CrCbGaD
Spironolactone—ABCB1—adipose tissue—atherosclerosis	0.00021	0.00742	CbGeAlD
Spironolactone—Progesterone—ESR1—atherosclerosis	0.000178	0.139	CrCbGaD
Spironolactone—ABCB1—liver—atherosclerosis	0.000147	0.0052	CbGeAlD
Spironolactone—Methyltestosterone—ALB—atherosclerosis	0.000129	0.101	CrCbGaD
Spironolactone—Testosterone—ALB—atherosclerosis	7.5e-05	0.0585	CrCbGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.54e-05	0.000221	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LIPC—atherosclerosis	2.54e-05	0.000221	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARA—atherosclerosis	2.53e-05	0.000221	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.52e-05	0.00022	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOC3—atherosclerosis	2.52e-05	0.00022	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—atherosclerosis	2.52e-05	0.000219	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LDLR—atherosclerosis	2.51e-05	0.000219	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.49e-05	0.000217	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PARP1—atherosclerosis	2.49e-05	0.000217	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GHRL—atherosclerosis	2.49e-05	0.000217	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLAT—atherosclerosis	2.49e-05	0.000217	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	2.48e-05	0.000216	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—LPL—atherosclerosis	2.47e-05	0.000215	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	2.47e-05	0.000215	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AGT—atherosclerosis	2.45e-05	0.000214	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CETP—atherosclerosis	2.45e-05	0.000213	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.44e-05	0.000213	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.44e-05	0.000213	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARA—atherosclerosis	2.42e-05	0.000211	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPX1—atherosclerosis	2.41e-05	0.00021	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	2.41e-05	0.00021	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	2.41e-05	0.00021	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—atherosclerosis	2.4e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CAV1—atherosclerosis	2.38e-05	0.000207	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOA1—atherosclerosis	2.37e-05	0.000207	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CD36—atherosclerosis	2.35e-05	0.000205	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SCARB1—atherosclerosis	2.34e-05	0.000204	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.28e-05	0.000199	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG8—atherosclerosis	2.28e-05	0.000199	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LTA4H—atherosclerosis	2.28e-05	0.000199	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	2.24e-05	0.000195	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—atherosclerosis	2.22e-05	0.000194	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SIRT1—atherosclerosis	2.22e-05	0.000194	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMGCR—atherosclerosis	2.21e-05	0.000193	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PARP1—atherosclerosis	2.21e-05	0.000193	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—atherosclerosis	2.2e-05	0.000192	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KNG1—atherosclerosis	2.18e-05	0.00019	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARA—atherosclerosis	2.18e-05	0.00019	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.18e-05	0.00019	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.17e-05	0.000189	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGTR1—atherosclerosis	2.17e-05	0.000189	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	2.17e-05	0.000189	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CG—atherosclerosis	2.17e-05	0.000189	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLG—atherosclerosis	2.11e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AGT—atherosclerosis	2.11e-05	0.000184	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR2—atherosclerosis	2.09e-05	0.000183	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—atherosclerosis	2.09e-05	0.000182	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG1—atherosclerosis	2.07e-05	0.000181	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—atherosclerosis	2.07e-05	0.00018	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—INS—atherosclerosis	2.05e-05	0.000179	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CAV1—atherosclerosis	2.05e-05	0.000179	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.05e-05	0.000178	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOA1—atherosclerosis	2.05e-05	0.000178	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—atherosclerosis	2e-05	0.000175	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SOCS3—atherosclerosis	2e-05	0.000175	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2e-05	0.000174	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.98e-05	0.000172	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCA1—atherosclerosis	1.97e-05	0.000172	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.97e-05	0.000172	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LCAT—atherosclerosis	1.95e-05	0.00017	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FABP4—atherosclerosis	1.95e-05	0.00017	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP3—atherosclerosis	1.93e-05	0.000169	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—atherosclerosis	1.93e-05	0.000168	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF2—atherosclerosis	1.93e-05	0.000168	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA4—atherosclerosis	1.91e-05	0.000167	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—atherosclerosis	1.88e-05	0.000164	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.88e-05	0.000164	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOB—atherosclerosis	1.87e-05	0.000163	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—atherosclerosis	1.87e-05	0.000163	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARA—atherosclerosis	1.85e-05	0.000161	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDN1—atherosclerosis	1.84e-05	0.00016	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL5—atherosclerosis	1.83e-05	0.000159	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SERPINE1—atherosclerosis	1.81e-05	0.000157	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG1—atherosclerosis	1.8e-05	0.000157	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—atherosclerosis	1.8e-05	0.000157	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—atherosclerosis	1.8e-05	0.000157	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.79e-05	0.000156	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LPL—atherosclerosis	1.78e-05	0.000156	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.78e-05	0.000155	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—INS—atherosclerosis	1.77e-05	0.000154	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.75e-05	0.000152	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCG—atherosclerosis	1.74e-05	0.000151	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.74e-05	0.000151	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.71e-05	0.000149	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LCAT—atherosclerosis	1.7e-05	0.000148	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FABP4—atherosclerosis	1.7e-05	0.000148	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMOX1—atherosclerosis	1.69e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SPP1—atherosclerosis	1.69e-05	0.000147	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SIRT1—atherosclerosis	1.69e-05	0.000147	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.68e-05	0.000146	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—atherosclerosis	1.67e-05	0.000146	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.67e-05	0.000145	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA4—atherosclerosis	1.66e-05	0.000145	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA2—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.65e-05	0.000143	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.64e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.62e-05	0.000142	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.62e-05	0.000142	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOB—atherosclerosis	1.62e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—atherosclerosis	1.62e-05	0.000141	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.61e-05	0.000141	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—atherosclerosis	1.58e-05	0.000138	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPA—atherosclerosis	1.57e-05	0.000137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFB—atherosclerosis	1.56e-05	0.000136	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—atherosclerosis	1.55e-05	0.000135	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LPL—atherosclerosis	1.55e-05	0.000135	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.55e-05	0.000135	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—atherosclerosis	1.53e-05	0.000133	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AGT—atherosclerosis	1.53e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.53e-05	0.000133	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BGN—atherosclerosis	1.52e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.51e-05	0.000132	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—atherosclerosis	1.51e-05	0.000132	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.51e-05	0.000132	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA5—atherosclerosis	1.5e-05	0.000131	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—atherosclerosis	1.5e-05	0.00013	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—atherosclerosis	1.5e-05	0.00013	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—atherosclerosis	1.48e-05	0.000129	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.48e-05	0.000129	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.48e-05	0.000129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOA1—atherosclerosis	1.48e-05	0.000129	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD36—atherosclerosis	1.47e-05	0.000128	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.46e-05	0.000127	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.45e-05	0.000126	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALOX15—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA2—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.42e-05	0.000124	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—atherosclerosis	1.42e-05	0.000124	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG5—atherosclerosis	1.42e-05	0.000123	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.42e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—F2—atherosclerosis	1.41e-05	0.000123	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARA—atherosclerosis	1.4e-05	0.000122	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.4e-05	0.000122	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.000122	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.38e-05	0.00012	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—atherosclerosis	1.38e-05	0.00012	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARA—atherosclerosis	1.37e-05	0.000119	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPA—atherosclerosis	1.37e-05	0.000119	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—atherosclerosis	1.35e-05	0.000118	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AGT—atherosclerosis	1.32e-05	0.000115	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BGN—atherosclerosis	1.32e-05	0.000115	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA5—atherosclerosis	1.31e-05	0.000114	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—atherosclerosis	1.3e-05	0.000113	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—atherosclerosis	1.3e-05	0.000113	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.29e-05	0.000113	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—atherosclerosis	1.29e-05	0.000112	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—atherosclerosis	1.28e-05	0.000111	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—atherosclerosis	1.27e-05	0.000111	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.26e-05	0.00011	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—atherosclerosis	1.26e-05	0.00011	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.25e-05	0.000109	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.25e-05	0.000109	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.25e-05	0.000109	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LIPC—atherosclerosis	1.25e-05	0.000109	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOC3—atherosclerosis	1.24e-05	0.000108	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—atherosclerosis	1.24e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LDLR—atherosclerosis	1.23e-05	0.000107	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALOX5—atherosclerosis	1.22e-05	0.000106	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CETP—atherosclerosis	1.2e-05	0.000105	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—atherosclerosis	1.17e-05	0.000102	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—atherosclerosis	1.17e-05	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.17e-05	0.000102	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	1.17e-05	0.000102	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—atherosclerosis	1.16e-05	0.000101	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.15e-05	0.0001	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—atherosclerosis	1.13e-05	9.86e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.12e-05	9.78e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—atherosclerosis	1.12e-05	9.77e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—atherosclerosis	1.11e-05	9.67e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAMPT—atherosclerosis	1.09e-05	9.53e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.09e-05	9.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LIPC—atherosclerosis	1.09e-05	9.47e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOC3—atherosclerosis	1.08e-05	9.41e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LDLR—atherosclerosis	1.07e-05	9.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CETP—atherosclerosis	1.05e-05	9.14e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	1.04e-05	9.1e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.03e-05	8.97e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—atherosclerosis	1.02e-05	8.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SCARB1—atherosclerosis	1e-05	8.75e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—atherosclerosis	9.94e-06	8.67e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.81e-06	8.55e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—atherosclerosis	9.72e-06	8.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCA1—atherosclerosis	9.7e-06	8.45e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMGCR—atherosclerosis	9.48e-06	8.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.29e-06	8.1e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—atherosclerosis	8.99e-06	7.84e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—atherosclerosis	8.95e-06	7.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKB1—atherosclerosis	8.9e-06	7.76e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—atherosclerosis	8.89e-06	7.75e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK8—atherosclerosis	8.75e-06	7.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCA1—atherosclerosis	8.45e-06	7.36e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—atherosclerosis	8.32e-06	7.25e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—atherosclerosis	8.27e-06	7.21e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—atherosclerosis	8.07e-06	7.04e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—atherosclerosis	8e-06	6.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOB—atherosclerosis	7.97e-06	6.95e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—atherosclerosis	7.92e-06	6.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—atherosclerosis	7.75e-06	6.76e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—atherosclerosis	7.64e-06	6.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPL—atherosclerosis	7.61e-06	6.63e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—atherosclerosis	7.42e-06	6.47e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—atherosclerosis	7.41e-06	6.46e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—atherosclerosis	7.25e-06	6.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD36—atherosclerosis	7.23e-06	6.3e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—atherosclerosis	7.13e-06	6.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOB—atherosclerosis	6.94e-06	6.05e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—atherosclerosis	6.85e-06	5.97e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—atherosclerosis	6.79e-06	5.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—atherosclerosis	6.75e-06	5.89e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARA—atherosclerosis	6.72e-06	5.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPL—atherosclerosis	6.63e-06	5.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AGT—atherosclerosis	6.51e-06	5.67e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—atherosclerosis	6.47e-06	5.64e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—atherosclerosis	6.38e-06	5.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—atherosclerosis	6.32e-06	5.51e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOA1—atherosclerosis	6.3e-06	5.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD36—atherosclerosis	6.3e-06	5.49e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—atherosclerosis	6.04e-06	5.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—atherosclerosis	5.97e-06	5.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARA—atherosclerosis	5.85e-06	5.1e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	5.76e-06	5.02e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AGT—atherosclerosis	5.67e-06	4.94e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—atherosclerosis	5.58e-06	4.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—atherosclerosis	5.56e-06	4.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—atherosclerosis	5.55e-06	4.84e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—atherosclerosis	5.5e-06	4.8e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOA1—atherosclerosis	5.49e-06	4.79e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—atherosclerosis	5.45e-06	4.75e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—atherosclerosis	5.15e-06	4.49e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.01e-06	4.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—atherosclerosis	4.99e-06	4.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—atherosclerosis	4.84e-06	4.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—atherosclerosis	4.78e-06	4.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—atherosclerosis	4.75e-06	4.14e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—atherosclerosis	4.58e-06	3.99e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—atherosclerosis	4.47e-06	3.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—atherosclerosis	4.37e-06	3.81e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—atherosclerosis	4.35e-06	3.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—atherosclerosis	4.16e-06	3.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—atherosclerosis	3.81e-06	3.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—atherosclerosis	2.2e-06	1.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—atherosclerosis	1.91e-06	1.67e-05	CbGpPWpGaD
